Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Epigenomics AG    ECX   DE000A11QW50

EPIGENOMICS AG

(ECX)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
3.425 3.41 2.6 2.685 2.6 Last
3965 11189 96181 48552 38195 Volume
-2.14% -0.44% -23.75% +3.27% -3.17% Change
Financials
Sales 2020 0,83 M 1,01 M 1,01 M
Net income 2020 -10,9 M -13,2 M -13,2 M
Net Debt 2020 0,49 M 0,59 M 0,59 M
P/E ratio 2020 -1,39x
Yield 2020 -
Sales 2021 7,55 M 9,19 M 9,19 M
Net income 2021 -12,9 M -15,8 M -15,8 M
Net Debt 2021 9,32 M 11,3 M 11,3 M
P/E ratio 2021 -1,29x
Yield 2021 -
Capitalization 15,3 M 18,6 M 18,6 M
EV / Sales 2020 19,0x
EV / Sales 2021 3,26x
Nbr of Employees 38
Free-Float 80,6%
More Financials
Company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The Company's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the... 
More about the company
Notations Surperformance© of Epigenomics AG
Trading Rating : Investor Rating :
More Ratings
All news about EPIGENOMICS AG
01/19EPIGENOMICS : U.S. Centers for Medicare & Medicaid Services publish negative NCD..
EQ
2020ORIGINAL-RESEARCH : Epigenomics AG (von First Berlin Equity Research GmbH): Kauf..
DJ
2020EQS/ORIGINAL-RESEARCH : Epigenomics AG (von First Berlin Equity Research GmbH): ..
DJ
2020EPIGENOMICS AG : REVERSE SPLIT: 1 of 8
FA
2020DGAP-NVR : Epigenomics AG: Release according to Article 41 of the WpHG [the Germ..
DJ
2020EPIGENOMICS : reports financial results for the first nine months of 2020
EQ
2020EPIGENOMICS AG : Preliminary announcement of the publication of quarterly report..
EQ
2020EPIGENOMICS AG : Capital reduction and further authorization to issue convertibl..
EQ
2020EPIGENOMICS AG : Notification and public disclosure of transactions by persons
EQ
2020EPIGENOMICS AG : Notice of Loss pursuant to § 92 par. 1 AktG
EQ
2020EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
2020EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
2020EPIGENOMICS AG : Notification and public disclosure of transactions by persons
EQ
2020EPIGENOMICS : hosts conference call on preliminary CMS reimbursement decision
EQ
2020EPIGENOMICS AG : U.S. Centers for Medicare & Medicaid Services publish negative ..
EQ
More news
News in other languages on EPIGENOMICS AG
01/20EPIGENOMICS AG : Korrektur einer Veröffentlichung vom 19.01.2021 gemäß § 40 Abs...
01/19EPIGENOMICS : Staatliche US-Krankenversicherung Centers for Medicare & Medicaid ..
01/19Staatliche US-Krankenversicherung Centers for Medicare & Medicaid Services ve..
01/19EPIGENOMICS AG : Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europa..
01/07Epigenomics AG gibt Pflichtwandelschuldverschreibung in Höhe von bis zu EUR 5..
More news
Analyst Recommendations on EPIGENOMICS AG
More recommendations
Chart EPIGENOMICS AG
Duration : Period :
Epigenomics AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EPIGENOMICS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 16,27 €
Last Close Price 2,60 €
Spread / Highest target 915%
Spread / Average Target 526%
Spread / Lowest Target 146%
EPS Revisions
Managers and Directors
NameTitle
Gregory K. Hamilton Chief Executive Officer
Jorge A. Garces President & Chief Scientific Officer
Heino von Prondzynski Chairman-Supervisory Board
Albert Weber Executive Vice President-Finance
Günther Reiter Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
EPIGENOMICS AG-23.53%19
EXACT SCIENCES CORPORATION13.22%23 548
GUARDANT HEALTH, INC.24.08%16 202
BGI GENOMICS CO., LTD.38.46%10 188
INVITAE CORPORATION32.05%9 388
ADAPTIVE BIOTECHNOLOGIES CORPORATION14.56%9 165